Form 4: Thermo Fisher Scientific CFO Stephen Williamson Executes Stock Option and Sells Shares
SEC Form 4
Stephen Williamson, CFO of Thermo Fisher Scientific, exercised stock options and sold shares of common stock on February 3rd and 4th, 2025, according to a recent SEC Form 4 filing.
Summary
- Stephen Williamson, the Senior VP and CFO of Thermo Fisher Scientific, engaged in transactions involving the company's common stock on February 3rd and 4th, 2025.
- He exercised stock options to acquire 9,825 shares on each day at a price of $253.99 per share.
- Simultaneously, he sold 9,825 shares on each day at prices of $593.13 and $585.59 respectively.
- Following these transactions, Williamson directly owns 27,295.809 shares of common stock and indirectly owns 12,674 shares through a SLAT.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 22, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan suggests the sales were pre-planned and intended to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a standard practice for corporate insiders to sell shares without raising concerns about insider trading.
- The size and frequency of these transactions are typical for executives at large, publicly traded companies like Thermo Fisher Scientific.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information being used.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2020-02-26 | First vesting date of the stock options. |
| 2021-02-26 | Second vesting date of the stock options. |
| 2022-02-26 | Third vesting date of the stock options. |
| 2022-11-15 | Reporting person contributed 18,700 shares of common stock to a grantor retained annuity trust. |
| 2023-02-26 | Fourth vesting date of the stock options. |
| 2024-08-22 | Date the Rule 10b5-1 trading plan was adopted. |
| 2024-12-11 | Termination date of the grantor retained annuity trust. |
| 2025-02-03 | Stephen Williamson exercised stock options and sold shares of common stock. |
| 2025-02-04 | Stephen Williamson exercised stock options and sold shares of common stock. |
| 2026-02-26 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.